Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2021   100,192,562    
Beginning balance at Dec. 31, 2021 $ 300,624,207 $ 100,193 $ 553,472,292 $ (252,948,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation 1,521,910   1,521,910  
Net income 7,112,043     7,112,043
Ending balance (in shares) at Mar. 31, 2022   100,192,562    
Ending balance at Mar. 31, 2022 309,258,160 $ 100,193 554,994,202 (245,836,235)
Beginning balance (in shares) at Dec. 31, 2022   175,530,212    
Beginning balance at Dec. 31, 2022 661,103,391 $ 175,530 775,241,114 (114,313,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of common warrants issued in offering (in shares)   4,517,427    
Exercise of common warrants issued in offering 3,613,941 $ 4,517 3,609,424  
Restricted stock vested (in shares)   659,479    
Restricted stock vested 0 $ 659 (659)  
Shares to cover tax withholding for restricted stock vested (in shares)   (79,634)    
Shares to cover tax withholdings for restricted stock vested 0 $ (79) 79  
Payments to cover tax withholdings for restricted stock vested, net (134,381)   (134,381)  
Share-based compensation 1,943,696   1,943,696  
Net income 32,715,779     32,715,779
Ending balance (in shares) at Mar. 31, 2023   180,627,484    
Ending balance at Mar. 31, 2023 $ 699,242,426 $ 180,627 $ 780,659,273 $ (81,597,474)